Eosinophilic fasciitis
DOI:
https://doi.org/10.47196/da.v31i2.2867Keywords:
fasciitis, eosinophilia, sclerodermaAbstract
Eosinophilic fasciitis is a scleroderma-like syndrome that involves the deep fascia and subcutaneous cellular tissue. It manifests with edema and symmetrical induration of the extremities that can progress to fibrosis and cause functional limitation. The diagnosis is made based on the clinical features, the results of histopathology and typical magnetic resonance imaging findings. The treatment of choice is systemic steroids. Three clinical cases assisted in our department are presented.
References
I. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians. 1975;88:70-86.
II. Fiesta L, Carricondo E, Wash A, Garrido A, et ál. Fascitis eosinofílica: comunicación de tres casos en fases aguda y crónica de la enfermedad. Dermatol Argent. 2013;19: 279-281.
III. Correa AL, Londoño Á, Ruiz AC, Mesa M. Eosinophilic fasciitis: a case report. Rev Colomb Reumatol. 2018;25:63-68.
IV. Li Y, Kong HE, Cheeley J. Eosinophilic fasciitis following COVID-19: a case series of 3 patients. JAAD Case Reports 2024;44:6-10.
V. Sprow G, Dan J, Abbott J, Jiang A, et ál. Sclerotic skin disease development following COVID-19 vaccination. JAAD Case Reports 2022;22:74-77.
VI. Antuña VL, Puchades F, Tapial JM, Ribelles JC, et ál. Eosinophilic fasciitis following SARS-CoV-2 vaccination. JAAD Case Reports. 2023;36:11-14.
VII. Boussaa H, Kamoun M, Miladi S, Makhlouf Y, et ál. The first case of SARS-CoV-2-induced eosinophilic fasciitis. Mod Rheumatol Case. 2024;8:224-228.
VIII. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, et ál. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1988;17:221-231.
IX. García MP, Lazo C, Rojas C. Fascitis eosinofílica: a propósito de un caso. Rev Chil Reumatol. 2015;24-29
X. Chiesura V, Vásquez M, Valente E, Kurpis M, et ál. Fascitis eosinofílica: a propósito de un caso. Rev Argent Dermatol. 2014;95:27-30.
XI. Armengot-Carbó M, Velasco-Pastor M, Navarro-Conde P, Gimeno-Carpio E. Fascitis eosinofílica asociada a traumatismo: utilidad diagnóstica de la resonancia magnética. Actas Dermosifiliogr. 2011;(102)8:640-642.
XII. Moreno L, Cornelio G, Comellas L, Díaz EJ, et ál. Fascitis eosinofílica. Acta médica Grupo Ángeles 2019;17:390-394.
XIII. Jinnin M, Yamamoto T, Asano Y, Ishikawa O, et ál. Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis. J Dermatol. 2018;45:881-890.
XIV. Lebeaux D, Frances C, Barete S, Wechsler B, et ál. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology. 2012;51:557561.
XV. Wright NA, Mazori DR, Patel M, Merola JF, et ál. Epidemiology and treatment of eosinophilic fasciitis. JAMA Dermatol. 2016;152:97-99.
XVI. Bukiej A, Dropiński J, Dyduch G, Szczeklik A. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol. 2005;24:634-636.
XVII. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008;47(1):29-35.
XVIII. Khanna D, Agrawal H, Clements PJ. Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases. Rheumatology (Oxford). 2010; 49(6):1184-1188.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 on behalf of the authors. Reproduction rights: Argentine Society of Dermatology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.
Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor
